SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$69.52
−0.83%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- -$2.58
- Revenue estimate
- $100.0K
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$1.13
- EPS estimate
- -$2.36
- Revenue actual
- $591.0K
- Revenue estimate
- $75.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -67.5%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $198
- PT range
- $110 – $285
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026